1. Home
  2. IRIX vs AIMD Comparison

IRIX vs AIMD Comparison

Compare IRIX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.94

Market Cap

20.2M

Sector

Health Care

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$2.43

Market Cap

16.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
AIMD
Founded
1989
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
16.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IRIX
AIMD
Price
$0.94
$2.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
106.9K
43.8K
Earning Date
11-11-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,647,000.00
$113,037.00
Revenue This Year
$9.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.58
178.19
52 Week Low
$0.78
$1.78
52 Week High
$1.90
$5.00

Technical Indicators

Market Signals
Indicator
IRIX
AIMD
Relative Strength Index (RSI) 44.46 45.20
Support Level $0.91 $2.03
Resistance Level $0.97 $2.56
Average True Range (ATR) 0.04 0.18
MACD 0.00 0.08
Stochastic Oscillator 44.72 78.21

Price Performance

Historical Comparison
IRIX
AIMD

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: